Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer

Mattijs Elschot; Kirsten M. Selnæs; Elise Sandsmark; Brage Krüger-Stokke; Øystein Størkersen; Guro F. Giskeødegård; May-Britt Tessem; Siver A. Moestue; Helena Bertilsson; Tone F. Bathen

doi:10.2967/jnumed.117.198598

Research ArticleOncology

Combined ¹⁸F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer

Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson and Tone F. Bathen

Journal of Nuclear Medicine May 2018, 59 (5) 762-768; DOI: https://doi.org/10.2967/jnumed.117.198598

Mattijs Elschot

1Department of Circulation and Medical Imaging, NTNU: Norwegian University of Science and Technology, Trondheim, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kirsten M. Selnæs

1Department of Circulation and Medical Imaging, NTNU: Norwegian University of Science and Technology, Trondheim, Norway

2St. Olavs Hospital, Trondheim, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Elise Sandsmark

1Department of Circulation and Medical Imaging, NTNU: Norwegian University of Science and Technology, Trondheim, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Brage Krüger-Stokke

1Department of Circulation and Medical Imaging, NTNU: Norwegian University of Science and Technology, Trondheim, Norway

3Department of Radiology, St. Olavs Hospital, Trondheim, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Øystein Størkersen

4Department of Pathology, St. Olavs Hospital, Trondheim, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Guro F. Giskeødegård

1Department of Circulation and Medical Imaging, NTNU: Norwegian University of Science and Technology, Trondheim, Norway

2St. Olavs Hospital, Trondheim, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

May-Britt Tessem

1Department of Circulation and Medical Imaging, NTNU: Norwegian University of Science and Technology, Trondheim, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Siver A. Moestue

5Department of Laboratory Medicine, Children’s and Women’s Health, NTNU: Norwegian University of Science and Technology, Trondheim, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Helena Bertilsson

6Department of Urology, St. Olavs Hospital, Trondheim, Norway; and

7Department of Cancer Research and Molecular Medicine, NTNU: Norwegian University of Science and Technology, Trondheim, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tone F. Bathen

1Department of Circulation and Medical Imaging, NTNU: Norwegian University of Science and Technology, Trondheim, Norway

2St. Olavs Hospital, Trondheim, Norway

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 59, Issue 5

May 1, 2018

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Combined 18F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Combined ¹⁸F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer

Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson, Tone F. Bathen

Journal of Nuclear Medicine May 2018, 59 (5) 762-768; DOI: 10.2967/jnumed.117.198598

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Combined ¹⁸F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer

Mattijs Elschot, Kirsten M. Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, Guro F. Giskeødegård, May-Britt Tessem, Siver A. Moestue, Helena Bertilsson, Tone F. Bathen

Journal of Nuclear Medicine May 2018, 59 (5) 762-768; DOI: 10.2967/jnumed.117.198598

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

The Effect of Including Bone in Dixon-Based Attenuation Correction for 18F-Fluciclovine PET/MRI of Prostate Cancer

Google Scholar

Oncology

Role of F18-FDG PET/CT in non-cutaneous melanomas.
The role of Lymphoscintigraphy in Breast Cancer Reccurence
Utility of bone scans in patients with RCC

Show more Oncology

Clinical

Addition of ¹³¹I-MIBG to PRRT (⁹⁰Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
SUVs Are Adequate Measures of Lesional ¹⁸F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?

Show more Clinical

Keywords

fluciclovine
FACBC
prostate cancer
PET/MRI
PLS-DA

Main menu

User menu

Search

Combined ¹⁸F-Fluciclovine PET/MRI Shows Potential for Detection and Characterization of High-Risk Prostate Cancer

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oncology

Clinical

Similar Articles

Keywords